Cargando…
Potential Breast Anticancer Drug Targets Revealed by Differential Gene Regulatory Network Analysis and Molecular Docking: Neoadjuvant Docetaxel Drug as a Case Study
Understanding gene-gene interaction and its causal relationship to protein-protein interaction is a viable route for understanding drug action at the genetic level, which is largely hindered by inability to robustly map gene regulatory networks. Here, we use biological prior knowledge of family-to-f...
Autores principales: | Aloraini, Adel, ElSawy, Karim M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808968/ https://www.ncbi.nlm.nih.gov/pubmed/29449773 http://dx.doi.org/10.1177/1176935118755354 |
Ejemplares similares
-
Biodegradable Magnetic
Molecularly Imprinted Anticancer
Drug Carrier for the Targeted Delivery of Docetaxel
por: Ali, Zeeshan, et al.
Publicado: (2022) -
Molecular Interaction of a Kinase Inhibitor Midostaurin with Anticancer Drug Targets, S100A8 and EGFR: Transcriptional Profiling and Molecular Docking Study for Kidney Cancer Therapeutics
por: Mirza, Zeenat, et al.
Publicado: (2015) -
Synthesis, Anticancer, Antioxidant, Anti-Inflammatory, Antimicrobial Activities, Molecular Docking, and DFT Studies of Sultams Derived from Saccharin
por: Al-Fayez, Nourah, et al.
Publicado: (2022) -
Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs
por: Choi, Jinhyang, et al.
Publicado: (2015) -
Evolution of drug regulations and regulatory innovation for anticancer drugs in China
por: Liu, Yang, et al.
Publicado: (2022)